Send to

Choose Destination
Antivir Ther. 1999;4 Suppl 3:7-11.

Sustained CD4 responses after virological failure of protease inhibitor-containing therapy.

Author information

University of California and San Francisco General Hospital, San Francisco, California, USA.


This article explores current controversies related to 'discordant' responses to antiviral therapy, that is to say, patients with a sustained CD4 cell response despite virological failure. Observational clinical data of patients receiving protease inhibitor-based therapy who had a sustained CD4 cell count even with incomplete viral suppression will be presented, as well as possible mechanisms and clinical implications.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center